Emily Rollins - Feb 8, 2022 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role: Director
Signature: /s/ Daniel Rodriguez, as Attorney-in-Fact for Emily Rollins
Stock symbol: DLB
Transactions as of: Feb 8, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/9/2022, 07:35 PM
Previous filing: Oct 12, 2021
Next filing: Mar 3, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Ownership	Footnotes
transaction	DLB	Class A Common Stock	+Grant/Award	$0	+2,783	+113.04%	$0.00	5,245	Feb 8, 2022	Direct	F1, F2

Explanation of Responses:

Id	Content
F1	Award represents a total of 2,783 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2023 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date.
F2	Shares held following the reported transactions include 2,783 restricted stock units, which are subject to forfeiture until they vest.

Content

Award represents a total of 2,783 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2023 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date.

Shares held following the reported transactions include 2,783 restricted stock units, which are subject to forfeiture until they vest.